Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

TLR9 Antikörper (AA 268-284) (PE)

TLR9 Reaktivität: Human IHC, FACS Wirt: Maus Monoclonal 4H286 PE

Produktnummer ABIN2376554

Datenblatt (PDF)

Target Alle TLR9 Antikörper anzeigen

TLR9 (Toll-Like Receptor 9 (TLR9))
Bindungsspezifität
16

10

8

5

5

4

3

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 268-284
Reaktivität
83

29

11

7

6

3

3

2

2

2

2

2

1

1

1
Human
Wirt
57

26

6

4

1
Maus
Passende Sekundärantikörper
Klonalität
62

32
Monoklonal
Konjugat
57

10

10

4

4

3

1

1

1

1

1

1
Dieser TLR9 Antikörper ist konjugiert mit PE
Applikation
60

42

39

33

18

15

11

8

7

5

2

2

2

1

1

1

1

1
Immunohistochemistry (IHC), Flow Cytometry (FACS)

Sequenz

CPRHFPQLHP DTFSHLS

Kreuzreaktivität

Hund, Pferd, Human, Affe, Maus, Ratte (Rattus)

Kreuzreaktivität (Details)

Calculated cross reactivity: Ca Eq Hu Mk Mo Rt

Produktmerkmale

TLR9 (Toll Like Receptor 9, CD289) (PE)

Aufreinigung

Purified by Protein G affinity chromatography.

Immunogen

Synthetic peptide corresponding to aa268-284, CPRHFPQLHPDTFSHLS of human TRL9, conjugated to KLH.

Klon

4H286

Isotyp

IgG1 kappa

Top Product

Discover our top product TLR9 Primärantikörper
anti-Toll-Like Receptor 9 (TLR9) (AA 868-1016) antibody
TLR9 Reaktivität: Human IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 1B12H2 unconjugated

anti-Toll-Like Receptor 9 (TLR9) (AA 28-362) antibody
TLR9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Toll-Like Receptor 9 (TLR9) (AA 26-193) antibody
TLR9 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 5B10E8 unconjugated

anti-Toll-Like Receptor 9 (TLR9) (AA 350-450) antibody
TLR9 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated

anti-Toll-Like Receptor 9 (TLR9) (AA 951-1032) antibody
TLR9 Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Toll-Like Receptor 9 (TLR9) antibody
TLR9 Reaktivität: Human WB, FACS, IHC (p), IF Wirt: Maus Monoclonal 5G5 unconjugated

anti-Toll-Like Receptor 9 (TLR9) (AA 99-215) antibody
TLR9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1E8 unconjugated

anti-Toll-Like Receptor 9 (TLR9) (N-Term) antibody
TLR9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Toll-Like Receptor 9 (TLR9) antibody (FITC)
TLR9 Reaktivität: Human WB, FACS, IHC (p), IF Wirt: Maus Monoclonal 5G5 FITC

anti-Toll-Like Receptor 9 (TLR9) (AA 26-332) antibody
TLR9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Buffer

Supplied as a liquid in PBS, pH 7.2, 0.05 % BSA, 0.05 % sodium azide.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

4 °C

Informationen zur Lagerung

4°C ,Do Not Freeze
Target

TLR9 (Toll-Like Receptor 9 (TLR9))

Andere Bezeichnung

TLR9 (TLR9 Produkte)

Pathways

TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades